search
Back to results

Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery

Primary Purpose

Disorders of Coagulation

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Lactated Ringer
Hydroxyethylstarch
Sponsored by
K. C. Rasmussen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Disorders of Coagulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient older than 18 years.
  • Indication for elective surgery with removal of the urine bladder.
  • Patient without anticoagulative, acethylsalisylsyre or NSAID medicine during the last 5 days,if using.

Exclusion Criteria:

  • Cerebral haemorrhage
  • Renal insufficiency demanding dialysis
  • Manifest cardiac and hepatic insufficiency
  • Disturbance in coagulation
  • Hypernatriæmi
  • Hyperchloræmi
  • Pregnant or nursing
  • Allergic to hydroxyethylstarch
  • Participating in another trial-if interferring the present trial
  • Incapable of managing his own affairs.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Ringer's lactate

    Arm Description

    Fluid therapy during operation

    Outcomes

    Primary Outcome Measures

    Estimate coagulation on basis of bloodsamples

    Secondary Outcome Measures

    Estimate coagulation by bloodloss and need for transfusion

    Full Information

    First Posted
    July 18, 2011
    Last Updated
    December 6, 2013
    Sponsor
    K. C. Rasmussen
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02009033
    Brief Title
    Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery
    Official Title
    Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery. A Randomised Clinical Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2013
    Overall Recruitment Status
    Completed
    Study Start Date
    September 2011 (undefined)
    Primary Completion Date
    April 2013 (Actual)
    Study Completion Date
    December 2013 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    K. C. Rasmussen

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this study is to investigate the effect of thin fluid with starch versus thin fluid without starch on coagulation in elective surgery when the patient is normovolæmic during operation.
    Detailed Description
    The primary goal is to register coagulation on basis of blood samples inclusive thromboelastography results. The secondary goal is to register blood loss and use of blood products during operation. The trial concerns 40 patients.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Disorders of Coagulation

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Ringer's lactate
    Arm Type
    Experimental
    Arm Description
    Fluid therapy during operation
    Intervention Type
    Drug
    Intervention Name(s)
    Lactated Ringer
    Intervention Description
    When normovolæmic status of the patient is secured, 35 ml/kg of the allocated fluid is infused during the operation (estimated time for this type of operation is 180 minutes), however max. 3500 ml.Lactated Ringer is the interventional medication.
    Intervention Type
    Drug
    Intervention Name(s)
    Hydroxyethylstarch
    Primary Outcome Measure Information:
    Title
    Estimate coagulation on basis of bloodsamples
    Time Frame
    6 months
    Secondary Outcome Measure Information:
    Title
    Estimate coagulation by bloodloss and need for transfusion
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient older than 18 years. Indication for elective surgery with removal of the urine bladder. Patient without anticoagulative, acethylsalisylsyre or NSAID medicine during the last 5 days,if using. Exclusion Criteria: Cerebral haemorrhage Renal insufficiency demanding dialysis Manifest cardiac and hepatic insufficiency Disturbance in coagulation Hypernatriæmi Hyperchloræmi Pregnant or nursing Allergic to hydroxyethylstarch Participating in another trial-if interferring the present trial Incapable of managing his own affairs.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Niels Henry Secher, Professor
    Organizational Affiliation
    Rigshospitalet , Dept. 2042, 2100 Copenhagen
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery

    We'll reach out to this number within 24 hrs